It has been nearly eight months since Tyler Lent and his family got the news that he had been diagnosed with Myelodysplastic Syndrome (MDS), a rare form of bone marrow cancer.
This item is available in full to subscribers.
To continue reading, you will need to either log in to your subscriber account, below, or purchase a new subscription.
Please log in to continue |
ROCHELLE – It has been nearly eight months since Tyler Lent and his family got the news that he had been diagnosed with Myelodysplastic Syndrome (MDS), a rare form of bone marrow cancer.
In January, doctors discovered the cancer had progressed into leukemia of the bone, which is extremely rare in children. Leukemia generally occurs within the blood, but in certain rare cases, can occur within the bone marrow.
“From what the doctors said was most of the time the condition occurs in older people, like over 55, it is hardly ever in kids. They said the number was like one in a million,” said Jessica Bays, Tyler’s aunt.
After receiving the diagnosis, the first step was to test to see if the cancer were genetic, so that Tyler might possibly receive a bone marrow transplant from one of his two siblings. The test came back negative, so physicians then had to test the siblings to determine who carried the closest gene. Even though they are biological siblings, it is not guaranteed to be a perfect match. The older sister came back as a 50 percent match and the youngest sister came back as a perfect 100 percent match.
After learning the younger sibling was a match, a chemotherapy treatment began. Lent received three rounds of chemotherapy, with each round lasting six days after which his body was given four weeks to recover before receiving another round of chemo.
“Me and my family were freaking out wondering why they would wait so long because the cancer cells can grow back,” Bays said. “But with the chemo it actually goes in his IV and it is so slow moving it actually takes a week for it to start working, and gives his body and his organs time to recover.”